Table 8.
Treatments | |||||
---|---|---|---|---|---|
Blood | PHY1 (n = 7) |
PHY2 (n = 7) |
CTRL + (n = 6) |
CRTL- (n = 7) |
p-value |
Total protein, g/L | 56.95 ± 2.67AB | 54.04 ± 2.67AB | 62.32 ± 2.89A | 50.83 ± 2.67B | 0.050 |
Hematocrit, % | 26.03 ± 1.05 | 26.09 ± 1.05 | 25.00 ± 1.16 | 25.43 ± 1.05 | 0.880 |
Albumin, g/L | 30.76 ± 2.85 | 32.05 ± 2.72 | 28.70 ± 3.06 | 26.11 ± 2.71 | 0.452 |
Globulin, g/L | 28.31 ± 2.63 | 26.20 ± 2.61 | 35.31 ± 2.86 | 24.43 ± 2.61 | 0.055 |
A/G ratio | 1.06 ± 0.09 | 1.09 ± 0.09 | 0.89 ± 0.09 | 1.14 ± 0.09 | 0.280 |
Urea, mmol/L | 2.51 ± 0.30 | 2.09 ± 0.30 | 2.90 ± 0.33 | 1.75 ± 0.30 | 0.093 |
ALT-GPT, IU/L | 26.51 ± 2.51 | 31.09 ± 2.54 | 24.52 ± 2.81 | 26.66 ± 2.54 | 0.375 |
AST-GOT, IU/L | 39.11 ± 6.79A | 72.02 ± 7.42B | 37.82 ± 7.05A | 43.59 ± 6.74AB | 0.014 |
ALP, UI/L | 170.30 ± 17.78 | 197.15 ± 17.71 | 149.83 ± 19.35 | 195.84 ± 18.32 | 0.262 |
Total bilirubin, µmol/l | 2.25 ± 0.16 | 1.86 ± 0.16 | 1.86 ± 0.17 | 1.70 ± 0.16 | 0.123 |
Glucose, mmol/L | 4.91 ± 0.28 | 5.52 ± 0.28 | 5.12 ± 0.31 | 4.91 ± 0.28 | 0.421 |
Total cholesterol, mmol/L | 2.17 ± 0.11 | 2.21 ± 0.11 | 2.20 ± 0.12 | 2.19 ± 0.11 | 0.992 |
Calcium, mmol/L | 2.55 ± 0.15 | 2.89 ± 0.15 | 2.49 ± 0.17 | 2.54 ± 0.15 | 0.243 |
Phosphorus, mmol/L | 2.78 ± 0.11 | 3.00 ± 0.11 | 2.87 ± 0.12 | 3.04 ± 0.13 | 0.426 |
Magnesium, mmol/L | 0.85 ± 0.04 | 0.91 ± 0.04 | 0.96 ± 0.04 | 0.87 ± 0.04 | 0.174 |
Data are presented as least squared means (LSMEANS) and standard errors (SE)
A/G albumin/globulin, ALT-GPT alanine aminotransferase, AST-GOT aspartate aminotransferase, ALP alkaline phosphatase, HDL high-density lipoprotein, LDL low density lipoprotein
A−BDifferent uppercase letters indicate statistically significant differences among treatment groups (p ≤ 0.05)